Patients remain cancer-free nearly 3 years after receiving experimental immunotherapy
All participants in a trial of bowel cancer patients remained cancer-free nearly three years after receiving an experimental treatment.Led by researchers at University College London and UCL Hospitals, the study suggests that a short course of immunotherapy before surgery could produce better results than the current standard of care for certain patients.The trial focused on 32 patients with stage 2 or 3 bowel cancer. These patients had tumors with a […]
